Charles River Laboratories (CRL) Tops Q4 EPS by 9c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Below Consensus
Go back to Charles River Laboratories (CRL) Tops Q4 EPS by 9c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Below Consensus| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 186.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $186.60 | 52 Week High | $89.18 | |||
| Open | $186.60 | 52 Week Low | $65.70 | |||
| Day High | $186.60 | P/E | 86.79 | |||
| Day Low | $186.60 | EPS | $2.15 | |||
| Volume | 116 | |||||
